Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 1
1980 1
1986 1
1987 1
1991 1
1992 2
1994 4
1995 3
1997 1
1999 3
2000 2
2001 1
2002 1
2003 1
2004 3
2005 3
2006 6
2007 9
2008 4
2009 10
2010 8
2011 12
2012 16
2013 9
2014 8
2015 15
2016 24
2017 13
2018 18
2019 15
2020 10
2021 24
2022 11
2023 12
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Results by year

Filters applied: . Clear all
Page 1
NKG2D and its ligands in cancer.
Dhar P, Wu JD. Dhar P, et al. Among authors: wu jd. Curr Opin Immunol. 2018 Apr;51:55-61. doi: 10.1016/j.coi.2018.02.004. Epub 2018 Mar 9. Curr Opin Immunol. 2018. PMID: 29525346 Free PMC article. Review.
The CXCL8-CXCR1/2 pathways in cancer.
Liu Q, Li A, Tian Y, Wu JD, Liu Y, Li T, Chen Y, Han X, Wu K. Liu Q, et al. Among authors: wu jd. Cytokine Growth Factor Rev. 2016 Oct;31:61-71. doi: 10.1016/j.cytogfr.2016.08.002. Epub 2016 Aug 25. Cytokine Growth Factor Rev. 2016. PMID: 27578214 Free PMC article. Review.
NK Cell Plasticity in Cancer.
Liu S, Dhar P, Wu JD. Liu S, et al. Among authors: wu jd. J Clin Med. 2019 Sep 19;8(9):1492. doi: 10.3390/jcm8091492. J Clin Med. 2019. PMID: 31546818 Free PMC article. Review.
Targeting CD73 to augment cancer immunotherapy.
Roh M, Wainwright DA, Wu JD, Wan Y, Zhang B. Roh M, et al. Among authors: wu jd. Curr Opin Pharmacol. 2020 Aug;53:66-76. doi: 10.1016/j.coph.2020.07.001. Epub 2020 Aug 7. Curr Opin Pharmacol. 2020. PMID: 32777746 Free PMC article. Review.
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma.
Bollu LR, Bommi PV, Monsen PJ, Zhai L, Lauing KL, Bell A, Kim M, Ladomersky E, Yang X, Platanias LC, Matei DE, Bonini MG, Munshi HG, Hashizume R, Wu JD, Zhang B, James CD, Chen P, Kocherginsky M, Horbinski C, Cameron MD, Grigorescu AA, Yamini B, Lukas RV, Schiltz GE, Wainwright DA. Bollu LR, et al. Among authors: wu jd. J Med Chem. 2022 Dec 8;65(23):15642-15662. doi: 10.1021/acs.jmedchem.2c00771. Epub 2022 Nov 21. J Med Chem. 2022. PMID: 36410047 Free PMC article.
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial.
Wu JD, Li JX, Liu J, Wang HM, Zhou GH, Li J, Wu D, Chen X, Feng Y, Qi XY, Wang X, Gou JB, Ma TL, Yang XY, Xu LF, Wan P, Zhu T, Wang ZF, Zhu FC; CanSino COVID-19 Study Group. Wu JD, et al. Lancet Infect Dis. 2023 Sep;23(9):1020-1030. doi: 10.1016/S1473-3099(23)00199-8. Epub 2023 May 19. Lancet Infect Dis. 2023. PMID: 37216958 Clinical Trial.
233 results